| Home Market Dynamics Macro Trends Sector Trends Company Insights AI Investing Strategies Sign Up Login |
Sector: Pharmaceuticals
| Merck & Co. is making significant strides in product and service development, particularly highlighted by the successful launch of Keytruda's subcutaneous version and ongoing innovations in oncology. The company is also addressing public health challenges through its active development of HIV treatments, which reinforces its market position. Growing new drug sales and the overall revenue outlook contribute positively to market confidence, showcasing Merck's robust product pipeline and sales performance. However, challenges in maintaining pipeline momentum and competition in the pharmaceutical sector could pose risks. |
| The price action of MERCK & CO. INC. (MRK) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The trend sentiment at -0.2 is modestly bearish. The market sentiment at 0.3 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next. There is no clear direction for MRK since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.6, and the negative at -0.3 on 2026-08-04. The forces of Valuation Sentiment (-1), Sector Price Trend (-0.8), and Stock Price Trend (-0.2) will drive down the price. The forces of Price Level Sentiment (0), Market Risk Appetite (0), Option Sentiment (1.5), and Sentiment towards Fundamentals (2.3) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
Sign up to reveice notifications on Market Movers
| MRK | ||||||||||||||||
| Date | Attention | Price | StdDev | Price Level | RSI | Hourly RSI | Change | 10 Day Trend | Trend Sentiment | Hourly Trend Sentiment | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-04 | 1%(0.1%) | 128.08 | 2.33% | 57 | 61 | 49 | 0.22% | 0.15% | -0.2 | 0 | 1% | 0.4 | Long | 55% | 2.3 | 2.2 |
| 2026-08-03 | 0%(0%) | 127.8 | 2.36% | 53 | 65 | 34 | -1.86% | 0.23% | 0.1 | -0.2 | 1% | 0.3 | Short | 55% | 2.3 | -1 |
| 2026-08-02 | 0%(0%) | 0.1 | -0.2 | 0.2 | 1.6 | -1 | ||||||||||
| 2026-08-01 | 0%(0%) | 0.1 | -0.2 | 0.5 | 1.9 | -1 | ||||||||||
| 2026-07-31 | 0%(0%) | 130.22 | 2.31% | 74 | 63 | 73 | 0.32% | 0.23% | 0.1 | 0.1 | 0.7% | 1 | Long | 55% | 1.7 | -1 |
| 2026-07-30 | 0%(0%) | 129.81 | 2.3% | 71 | 63 | 45 | -0.44% | 0.16% | 0.4 | 0.1 | 0.9% | 1.1 | Long | 55% | 1.5 | -1 |
| 2026-07-29 | 0%(0%) | 130.39 | 2.26% | 78 | 61 | 21 | -1.1% | 0.55% | 1 | -0.3 | 0.8% | 1.3 | Wait | 50% | 1.5 | -1 |
| 2026-07-28 | 0%(0%) | 131.84 | 2.18% | 92 | 62 | 47 | 0.82% | 0.87% | 1.5 | 0 | 0.7% | 1.2 | Long | 55% | 1.2 | -1 |
| 2026-07-27 | 0%(0%) | 130.76 | 2.07% | 86 | 54 | 48 | -0.26% | 0.55% | 1.3 | -0.2 | 0.4% | 1.3 | Wait | 50% | 2.4 | -1 |
| 2026-07-26 | 0%(0%) | 1.1 | -0.2 | 1.3 | 3.2 | -1 | ||||||||||
| Long is the preferred trading strategy with 55% chance of being right. Improving trend sentiment and positive hourly trend. Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | ||||||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | ||||||||||||||||
| 2026-08-04 17:02:23 Articles frequently reference fluctuations in Merck's stock performance correlating with earnings reports and news releases. |
| 2026-08-04 17:02:23 Merck’s clinical updates and regulatory achievements are prominent in discussions of their future growth potential. |
| 2026-08-04 17:02:23 Several articles mention Merck cutting its profit guidance due to acquisition costs, raising concerns regarding future profitability. |
| 2026-08-04 17:02:23 The discussion around the sales performance of Merck’s oncology products like Keytruda and the impact of new drug sales is a recurring theme. |
| 2026-08-04 17:02:23 Multiple articles discuss Merck's earnings performance, highlighting both beat estimates and losses. |
| 2026-08-04 15:47:29 Merck's decision to lower its earnings outlook is partly due to substantial charges from its acquisition of Terns, reflecting cost management issues. |
| 2026-08-04 15:47:29 The article highlights a significant decrease in Merck's profit outlook, indicating financial difficulties or challenges ahead. |
| 2026-08-04 13:47:37 Growth in Merck's oncology segment reflects strong product development and market positioning. |
| 2026-08-04 13:47:37 The rise in Merck's stock suggests positive investor sentiment and confidence in its oncology segment. |
| 2026-08-04 13:47:37 Merck's quarterly loss was narrower than expected, indicating a resilient performance despite challenges. |
| 2026-08-04 11:47:51 Merck's stock rose despite a cut in earnings guidance, showing resilience in stock performance amidst challenges. |
| 2026-08-04 11:47:51 The article focuses on the growth in Merck's oncology segment, indicating strong product performance and potential for future development. |
| 2026-08-04 11:47:51 The article highlights Merck's narrower-than-expected quarterly loss, suggesting a positive outlook on their earnings performance. |
| 2026-08-04 09:33:43 The growth in the oncology segment is a positive indicator of Merck's focus and success in a critical area of healthcare. |
| 2026-08-04 09:33:43 Despite the profit guidance cut, Merck posted a narrower-than-expected loss, indicating resilience in its earnings. |
| 2026-08-04 09:33:43 Merck's stock rise is significant, as it suggests investor confidence amid potentially troubling earnings news. |
| 2026-08-04 09:33:43 Merck's reduction in profit guidance reflects financial strain from acquisition-related costs, raising concerns over expense management. |
| 2026-08-04 09:33:43 The increase in revenue outlook driven by new drug sales highlights the success of Merck's product offerings. |